A detailed history of Lazard Asset Management LLC transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Lazard Asset Management LLC holds 2,267,013 shares of STVN stock, worth $42 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,267,013
Previous 2,417,595 6.23%
Holding current value
$42 Million
Previous $66 Million 10.3%
% of portfolio
0.09%
Previous 0.09%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.34 - $34.28 $3.82 Million - $5.16 Million
-150,582 Reduced 6.23%
2,267,013 $72.8 Million
Q4 2023

Feb 14, 2024

SELL
$25.21 - $34.66 $6.77 Million - $9.31 Million
-268,483 Reduced 10.0%
2,417,595 $66 Million
Q3 2023

Nov 14, 2023

SELL
$26.91 - $35.49 $9.85 Million - $13 Million
-366,189 Reduced 12.0%
2,686,078 $79.8 Million
Q2 2023

Aug 14, 2023

SELL
$25.15 - $32.86 $9.81 Million - $12.8 Million
-390,013 Reduced 11.33%
3,052,267 $98.8 Million
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $17.9 Million - $26.5 Million
-1,021,712 Reduced 22.89%
3,442,280 $89.2 Million
Q4 2022

Feb 14, 2023

SELL
$13.95 - $19.28 $3.52 Million - $4.86 Million
-251,982 Reduced 5.34%
4,463,992 $80.2 Million
Q3 2022

Nov 14, 2022

SELL
$14.66 - $18.3 $10.5 Million - $13.1 Million
-715,758 Reduced 13.18%
4,715,974 $79.9 Million
Q2 2022

Aug 09, 2022

SELL
$14.1 - $20.26 $13.2 Million - $18.9 Million
-934,947 Reduced 14.69%
5,431,732 $85.9 Million
Q1 2022

May 13, 2022

BUY
$15.23 - $21.47 $3.2 Million - $4.51 Million
210,007 Added 3.41%
6,366,679 $128 Million
Q4 2021

Feb 09, 2022

BUY
$21.65 - $27.0 $4.81 Million - $6 Million
222,395 Added 3.75%
6,156,672 $138 Million
Q3 2021

Nov 15, 2021

BUY
$19.51 - $28.7 $116 Million - $170 Million
5,934,277 New
5,934,277 $150 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $4.9B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.